Internal Medicine, Infectious Disease · Saint Louis, MO
NPI
1598085771
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
10004 Kennerly Rd Ste 171b
Saint Louis, MO, 63128
Phone (314) 821-0900
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
1,637 services
Medicare patients, 2024
384
Average age 72
Drug cost, 2024
$152K
658 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Uchenna T Ikediobi was code 99232 (hospital e&m - subsequent), 638 times for 231 patients. In total Uchenna T Ikediobi billed 1,637 services in 11 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 638 | 231 | $60.00 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 480 | 217 | $90.29 | $43K |
| 99223 Hospital E&M - Initial | Facility | 247 | 210 | $131.94 | $33K |
| 99214 Office E&M - Established | Office | 83 | 47 | $93.15 | $7,732 |
| 99231 Hospital E&M - Subsequent | Facility | 25 | 23 | $37.88 | $947 |
By year: 2022 $88K for 1,178 services; 2023 $141K for 1,736 services; 2024 $124K for 1,637 services.
Medicare prescription drug claims, 2024
In 2024, the drug Uchenna T Ikediobi prescribed most often to Medicare patients was Vancomycin Hcl, with 125 prescriptions and refills. In total Uchenna T Ikediobi wrote 658 Medicare prescriptions that cost $152K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 125 | 126 | 30 | $20K |
| Daptomycin Generic | 78 | 78 | 18 | $67K |
| Ceftriaxone Ceftriaxone Sodium | 74 | 74 | 13 | $3,103 |
| Cefepime Hcl Generic | 40 | 40 | Under 11 | $9,903 |
| Meropenem Generic | 38 | 38 | Under 11 | $7,613 |
| Ceftazidime Generic | 38 | 38 | Under 11 | $5,015 |
| Doxycycline Hyclate Generic | 26 | 46 | Under 11 | $928 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 19 | 19 | Under 11 | $2,166 |
| Micafungin Micafungin Sodium | 18 | 18 | Under 11 | $4,251 |
| Cefprozil Generic | 16 | 24 | Under 11 | $877 |
| Ciprofloxacin Hcl Generic | 15 | 17 | Under 11 | $214 |
| Levofloxacin Generic | 14 | 14 | Under 11 | $22.57 |
| Ertapenem Ertapenem Sodium | 14 | 14 | Under 11 | $5,118 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 12 | 12 | Under 11 | $589 |
| Cefazolin Sodium Generic | 12 | 12 | Under 11 | $484 |
Brand drugs: 50 claims; generic drugs: 608 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Uchenna T Ikediobi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.